These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 12053490)

  • 41. Monitoring the treatment of carcinoid disease using blood serotonin and plasma 5-hydroxyindoleacetic acid: three case examples.
    Allen KR; Degg TJ; Anthoney DA; Fitzroy-Smith D
    Ann Clin Biochem; 2007 May; 44(Pt 3):300-7. PubMed ID: 17456301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of lanreotide on prolactin level in patients with pituitary mixed tumors].
    Wasko R; Sawicka J; Stachowiak C; Kozak W; Junik R; Sowinski J
    Ann Endocrinol (Paris); 2002 Dec; 63(6 Pt 1):532-5. PubMed ID: 12527855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of advanced and/or metastatic carcinoid tumors: historical perspectives and emerging therapies.
    Nandy N; Dasanu CA
    Expert Opin Pharmacother; 2013 Aug; 14(12):1649-58. PubMed ID: 23746075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Somatostatin analogues in the treatment of the carcinoid syndrome.
    Deghenghi R
    Biomed Pharmacother; 1988; 42(9):585-8. PubMed ID: 2907298
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of lanreotide Autogel administered every 4-8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: a phase III trial.
    Lucas T; Astorga R;
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):320-6. PubMed ID: 16918950
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Somatostatin in the elderly: diurnal plasma profile and secretory response to meal stimulation.
    Rolandi E; Franceschini R; Messina V; Cataldi A; Salvemini M; Barreca T
    Gerontology; 1987; 33(5):296-301. PubMed ID: 2890557
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimal sampling interval for characterisation of the circadian rhythm of body temperature in homeothermic animals using periodogram and cosinor analysis.
    Goh G; Vesterdorf K; Fuller A; Blache D; Maloney SK
    Ecol Evol; 2024 Apr; 14(4):e11243. PubMed ID: 38601852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diurnal rhythmicity of endogenous TNF alpha concentration in plasma of advanced gastrointestinal cancer patients.
    Mucwierzgon M; Madej K; Baranowski M; Kokot T
    Oncol Rep; 1997; 4(3):637-40. PubMed ID: 21590114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radioimmunoassay of human plasma somatostatin.
    Mackes K; Itoh M; Greene K; Gerich J
    Diabetes; 1981 Sep; 30(9):728-34. PubMed ID: 6114887
    [No Abstract]   [Full Text] [Related]  

  • 50. Carcinoid tumors--somatostatine in the diagnosis and therapy.
    Kinova S; Duris I; Kratochvilova E; Ondrejka P; Payer J
    Bratisl Lek Listy; 2002; 103(3):108-12. PubMed ID: 12190042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tailored intermittent therapy of carcinoid.
    Kinová S; Duris I; Kratochvíl'ová E; Kovácová E; Koren M
    Hepatogastroenterology; 2007 Sep; 54(78):1716-9. PubMed ID: 18019702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circadian rhythmicity of plasma somatostatin, gastrin and cortisol in colon cancer patients.
    Payer J; Huorka M; Duris I; Ondrejka P; Kratochvílova H; Ilkova M; Holéczy P
    Hepatogastroenterology; 1997; 44(13):72-7. PubMed ID: 9058123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An update of lanreotide acetate for treatment of adults with carcinoid syndrome.
    Guadalupe E; Deshpande HA; Stein SM
    Drugs Today (Barc); 2018 Aug; 54(8):457-465. PubMed ID: 30209440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Diurnal rhythm of endogenous somatostatin in patients with carcinoid].
    Kinová S; Kovácová E; Kratochvíĺová E; Ondrejka P; Duris I
    Cesk Fysiol; 2002 May; 51(2):69-74. PubMed ID: 12053490
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.